DSC Advisors L.P. purchased a new position in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 80,000 shares of the company’s stock, valued at approximately $2,244,000. Tabula Rasa HealthCare accounts for 1.3% of DSC Advisors L.P.’s holdings, making the stock its 18th biggest position. DSC Advisors L.P. owned approximately 0.45% of Tabula Rasa HealthCare at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in TRHC. Strs Ohio purchased a new position in Tabula Rasa HealthCare during the 4th quarter worth $137,000. New York State Common Retirement Fund increased its holdings in Tabula Rasa HealthCare by 257.0% during the 2nd quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock worth $151,000 after purchasing an additional 7,199 shares during the period. BlueCrest Capital Management Ltd purchased a new position in Tabula Rasa HealthCare during the 4th quarter worth $237,000. Teachers Advisors LLC increased its holdings in Tabula Rasa HealthCare by 203.5% during the 2nd quarter. Teachers Advisors LLC now owns 16,500 shares of the company’s stock worth $248,000 after purchasing an additional 11,063 shares during the period. Finally, California State Teachers Retirement System increased its holdings in Tabula Rasa HealthCare by 60.2% during the 2nd quarter. California State Teachers Retirement System now owns 16,500 shares of the company’s stock worth $248,000 after purchasing an additional 6,200 shares during the period. Institutional investors own 53.03% of the company’s stock.
Shares of Tabula Rasa HealthCare Inc (TRHC) opened at $35.12 on Wednesday. The company has a quick ratio of 0.66, a current ratio of 0.73 and a debt-to-equity ratio of 0.47. Tabula Rasa HealthCare Inc has a 52-week low of $11.59 and a 52-week high of $39.81.
Several research firms have commented on TRHC. Oppenheimer raised their price objective on Tabula Rasa HealthCare from $35.00 to $47.00 and gave the stock an “outperform” rating in a report on Tuesday. William Blair reaffirmed an “outperform” rating on shares of Tabula Rasa HealthCare in a research report on Tuesday. Piper Jaffray Companies increased their target price on Tabula Rasa HealthCare to $43.00 and gave the company an “overweight” rating in a research report on Tuesday. Zacks Investment Research cut Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. Finally, CIBC reaffirmed an “outperform” rating and set a $47.00 target price (up previously from $35.00) on shares of Tabula Rasa HealthCare in a research report on Tuesday. Four research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Tabula Rasa HealthCare presently has a consensus rating of “Buy” and an average target price of $33.50.
In other news, CEO Calvin H. Knowlton sold 8,000 shares of the firm’s stock in a transaction on Monday, January 8th. The stock was sold at an average price of $32.75, for a total value of $262,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bruce Luehrs sold 252,242 shares of the firm’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $34.29, for a total value of $8,649,378.18. The disclosure for this sale can be found here. Insiders sold a total of 295,021 shares of company stock valued at $10,167,309 in the last three months. Insiders own 45.80% of the company’s stock.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.